For the quarter ended June 2024, Conmed (CNMD) reported revenue of $332.1 million, up 4.6% over the same period last year. EPS came in at $0.98, compared to $0.83 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $334.56 million, representing a surprise of -0.74%. The company delivered an EPS surprise of +6.52%, with the consensus EPS estimate being $0.92. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expe ...

Conmed (CNMD) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.83 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 6.52%. A quarter ago, it was expected that this medical technology company would post earnings of $0.74 per share when it actually produced earnings of $0.79, delivering a surprise of 6.76%. Over the last four quarters, the ...

CONMED Investor Presentation Q2 2024 Earnings Call Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer July 31, 2024 Forward-Looking Information 2 This presentation may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forwardlooking statements ...

| --- | --- | --- | --- | |-------|-------|-------|------------------------------------------------| | | | | NEWS RELEASE | | | | | CONTACT : | | | | | CONMED Corporation | | | | | Todd W. Garner Chief Financial Officer | | | | | 727-214-2975 | | | | | ToddGarner@conmed.com | CONMED Corporation Announces Second Quarter 2024 Financial Results Largo, Florida, July 31, 2024 – CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highli ...

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 31. On the other hand, if they miss, the stock may move lower. While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise. This medical technology company is expected to post quarterly ...

CONMED Corporation (CNMD) delivered adjusted earnings per share (EPS) of $0.79 in first-quarter 2024, which beat the Zacks Consensus Estimate of $0.74 by 6.8%. The bottom line improved 19.7% from the year-ago quarter’s level.GAAP EPS for the quarter was 63 cents compared with 6 cents per share in the year-ago period.The company’s shares have lost 25.8% in the past six months against the industry’s rise of 10.0%. The broader S&P 500 Index has gained 23% in the same time frame.Image Source: Zacks Investment R ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Common Stock, $0.01 par value CNMD NYSE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Smaller reporting company ☐ Emerging growth company ☐ The number of ...

Investor Presentation Q1 2024 Earnings Call This presentation may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forwardlooking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-lo ...

Call End: CONMED Corporation (NYSE:CNMD) Q1 2024 Earnings Conference Call April 24, 2024, 16:30 PM ET Company Participants Curt Hartman - Chair, President and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Matt O'Brien - Piper Sandler Young Li - Jefferies Vik Chopra - Wells Fargo Kristen Stewart - CL King Rick Wise - Stifel Robbie Marcus - J.P. Morgan Travis Steed - BofA Securities Mike Matson - Needham Operator Thank you for standing ...

For the quarter ended March 2024, Conmed (CNMD) reported revenue of $312.27 million, up 5.7% over the same period last year. EPS came in at $0.79, compared to $0.66 in the year-ago quarter.The reported revenue represents a surprise of +1.70% over the Zacks Consensus Estimate of $307.06 million. With the consensus EPS estimate being $0.74, the EPS surprise was +6.76%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ne ...